Safety of posterior interbody fusions of the lumbar spine using rhBMP-2.
Tomislav
T
Smoljanovic
Ivan
I
Bojanic
Zorka
Z
Vlahovic
D020341:Absorbable Implants / Q000009:adverse effects; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000009:adverse effects*; D001861:Bone Regeneration / Q000187:drug effects / Q000502:physiology; D001862:Bone Resorption / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D002828:Choristoma / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003094:Collagen / Q000627:therapeutic use; D006801:Humans; D015576:Hyperostosis / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D007049:Iatrogenic Disease / Q000517:prevention & control; D008159:Lumbar Vertebrae / Q000187:drug effects* / Q000473:pathology / Q000601:surgery; D017063:Outcome Assessment, Health Care; D011128:Polyradiculopathy / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D011183:Postoperative Complications / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D011994:Recombinant Proteins / Q000009:adverse effects*; D012086:Reoperation / Q000706:statistics & numerical data; D015203:Reproducibility of Results; D013115:Spinal Canal / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D013123:Spinal Fusion / Q000009:adverse effects* / Q000379:methods; D016212:Transforming Growth Factor beta / Q000009:adverse effects*; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology
D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2; D003094:Collagen